dailyRx News reports trending health conversations
AUSTIN, Texas, Oct. 3, 2012 /PRNewswire/ -- dailyRx, Inc., a leading digital news publisher, announced today the top five health conditions and medications viewed on the dailyRx News Network during September 2012. dailyRx News is syndicated to consumers across Patient Conversation's portfolio of websites and distributed to patients by its national provider network via hospital and practice websites and social networks.
"As a digital publisher, dailyRx is focused on making relevant, patient-friendly health news easily accessible," said Donald W. Hackett, CEO and Publisher of dailyRx News. "We are extending patient education beyond the point of care to empower more effective doctor-patient conversations and reduce the overall cost of care."
Health conditions generating notable viewer engagement last month included:
- Cancer 5.7 MM Pageviews
- Arthritis 4.3 MM Pageviews
- Allergies 3.1 MM Pageviews
- Diabetes 2.7 MM Pageviews
- Women's Health 2.5 MM Pageviews
September's most-viewed medications included:
- Mirapex, Boehringer Ingelheim
- Seroquel, AstraZeneca
- Cymbalta, Lilly
- Gleevec, Novartis
- Lexapro, Forest Laboratories
"Hospitals, clinics and health providers are utilizing dailyRx's Content-as-a-Service news feeds and social media solutions to maximize patient engagement," Hackett said. "Educated patients are more involved in managing their health, adhere to their doctors' therapy prescriptions more often, and reduce health expenses."
About The dailyRx News Network
The dailyRx News Network is an emerging leader in publishing health news for consumers and patients alike. dailyRx publishes, aggregates, and syndicates doctor-reviewed news covering a wide range of health conditions, medications, over-the-counter products, and nutraceutical compounds. dailyRx's original content is written in positive, unbiased, easy-to-understand language and reviewed for efficacy by doctors, pharmacists and therapists. dailyRx, Inc. is owned by Patient Conversation Media, Inc.
About Patient Conversation Media, Inc.
Patient Conversation Media, Inc. (PCMi) is a technology-driven media enterprise focused on the digital evolution within the health industry. PCMi's cloud-based Content-as-a-Service platform powers its DTC websites, distributes patient education solutions, and deploys a suite of appointment management solutions across Internet, Mobile, Social Media, and Telephony user experiences. PCMi's national network of physicians, pharmacists and behavioral health providers serves as the primary distribution channel for its solutions. PCMi's portfolio of owned and operated brands includes www.dailyrx.com/, www.RxWiki.com, www.1-800-Oncologist.com and www.1-800-Therapist.com.
SOURCE dailyRx, Inc.